Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Average …

Dec 24, 2024 · In other Rhythm Pharmaceuticals news, insider Joseph Shulman sold 13,281 shares of the stock in a transaction on Monday, November 11th. The shares were sold at an average price of $66.44, for a ...

$66.44
OFF

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Average …

1 week from now

etfdailynews.com

$35.17
OFF

Rhythm Pharmaceuticals (NASDAQ:RYTM) Earns Market …

1 week from now

Dec 23, 2024 · Rhythm Pharmaceuticals has a one year low of $35.17 and a one year high of $68.58. The company's fifty day moving average price is $56.51 and its two-hundred day …

marketbeat.com

$0.73
OFF

Rhythm Pharmaceuticals (RYTM) Stock Price, News & Analysis

1 week from now

Dec 20, 2024 · Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) announced its quarterly earnings data on Tuesday, November, 5th. The company reported ($0.73) earnings per share for the …

marketbeat.com

10%
OFF

Rhythm Pharmaceuticals, Inc. (RYTM) - Stock Analysis

1 week from now

According to 10 analysts, the average rating for RYTM stock is "Strong Buy." The 12-month stock price forecast is $66.9, which is an increase of 19.10% from the latest price. Price Target. ...

stockanalysis.com

$59
OFF

What 4 Analyst Ratings Have To Say About Rhythm Pharmaceuticals

1 week from now

Sep 18, 2024 · Analysts have recently evaluated Rhythm Pharmaceuticals and provided 12-month price targets. The average target is $59.5, accompanied by a high estimate of $64.00 …

nasdaq.com

2%
OFF

Rhythm Pharmaceuticals (NASDAQ: RYTM) - The Motley Fool

1 week from now

Rhythm Pharmaceuticals (NASDAQ: RYTM) $56.12 (1.2%) $0.64. Price as of December 20, 2024, 4:00 p.m. ET ... Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company, which …

fool.com

66%
OFF

Rhythm Pharmaceuticals (RYTM) Stock Forecast & Price Target

1 week from now

Jan 8, 2025 · Out of the 11 analysts, 1 has given a hold rating, and 10 have given a buy rating for RYTM. ... $68.09 17.66% Upside. According to the 11 analysts' twelve-month price targets for …

marketbeat.com

$55.24
OFF

Fmr LLC Grows Stock Holdings In Rhythm Pharmaceuticals, Inc.

1 week from now

Dec 15, 2024 · NASDAQ RYTM opened at $55.24 on Friday. The stock’s 50 day simple moving average is $55.66 and its 200 day simple moving average is $49.41. Rhythm Pharmaceuticals, …

etfdailynews.com

$0.73
OFF

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Consensus

1 week from now

4 days ago · Rhythm Pharmaceuticals (NASDAQ:RYTM - Get Free Report) last issued its quarterly earnings data on Tuesday, November 5th.The company reported ($0.73) earnings …

marketbeat.com

9%
OFF

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Sold By …

1 week from now

4 days ago · Harbor Capital Advisors Inc. trimmed its position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 26.9% in the fourth quarter, according to its most recent …

marketbeat.com

FAQs about Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Average … Coupon?

Should you buy Rhythm Pharmaceuticals (Rytm) stock?

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the ten research firms that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. ...

What is the 12-month price forecast for Rhythm Pharmaceuticals (Rytm)?

The 12-month stock price forecast is $63.7, which is an increase of 12.33% from the latest price. BOSTON, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rar... ...

What are Rhythm Pharmaceuticals' 1-year target prices?

The predicted 1-year target prices for Rhythm Pharmaceuticals' shares range from $27.00 to $56.00. On average, the brokers anticipate the company's share price to reach $37.17 in the next year, suggesting a possible upside of 48.0% from the stock's current price. ...

Is Rhythm Pharmaceuticals a good investment?

Rhythm Pharmaceuticals has received a consensus rating of Moderate Buy. Based on 5 buy ratings, 1 hold rating, and no sell ratings, the company's average rating score is 2.83. According to analysts, the forecasted upside for Rhythm Pharmaceuticals is 47.6%, with a consensus price target of $37.17, which is higher than its current price of $25.18. ...

How much money does Rhythm Pharmaceuticals make a year?

Rhythm Pharmaceuticals (NASDAQ:RYTM) has a market capitalization of $1.43 billion and generates $43.77 million in revenue each year. The company earns -$181,120,000.00 in net income (profit) each year or ($3.28) on an earnings per share basis. ...

Is Rhythm Pharmaceuticals traded on the NASDAQ?

Rhythm Pharmaceuticals trades on the NASDAQ under the ticker symbol "RYTM". Who are its major shareholders? Rhythm Pharmaceuticals' stock is owned by a variety of retail and institutional investors. ...